Htr6 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Attribute | Value | [@upton2008] |-----------|-------| [@ramirez2014] | Protein Name | Serotonin Receptor 6 | [@huang2017] | Gene Symbol | [htr6](/proteins/htr6-protein) | | UniProt ID | [P50406](https://www.uniprot.org/uniprot/P50406) | | Molecular Weight | ~45-50 kDa | | Subcellular Localization | Plasma membrane, dendrites | | Protein Family | 5-HT6 family (GPCR) | | Signal Transduction | Gs protein-coupled, stimulates adenylate cyclase |
</div>}
Overview
The Serotonin Receptor 6 (HTR6) is a Gs-coupled GPCR encoded by the [HTR6](/proteins/htr6-protein) gene. It is almost exclusively expressed in the brain, particularly in areas important for cognition and emotion (olfactory tubercle, nucleus accumbens, striatum, hippocampus). HTR6 has attracted interest as a cognitive enhancement target.
Structure
HTR6 has a typical GPCR structure with unique features:
Differential splicing: Generates isoforms with distinct pharmacological profiles
Cysteine residues: In extracellular loops for disulfide bond formation
Palmitoylation sites: For membrane localization
Unlike most 5-HT receptors, HTR6 exclusively couples to Gs proteins, making it unique in the 5-HT receptor family.
Normal Function
...
Serotonin Receptor 6 Protein
Introduction
Htr6 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Attribute | Value | [@upton2008] |-----------|-------| [@ramirez2014] | Protein Name | Serotonin Receptor 6 | [@huang2017] | Gene Symbol | [htr6](/proteins/htr6-protein) | | UniProt ID | [P50406](https://www.uniprot.org/uniprot/P50406) | | Molecular Weight | ~45-50 kDa | | Subcellular Localization | Plasma membrane, dendrites | | Protein Family | 5-HT6 family (GPCR) | | Signal Transduction | Gs protein-coupled, stimulates adenylate cyclase |
</div>}
Overview
The Serotonin Receptor 6 (HTR6) is a Gs-coupled GPCR encoded by the [HTR6](/proteins/htr6-protein) gene. It is almost exclusively expressed in the brain, particularly in areas important for cognition and emotion (olfactory tubercle, nucleus accumbens, striatum, hippocampus). HTR6 has attracted interest as a cognitive enhancement target.
Structure
HTR6 has a typical GPCR structure with unique features:
Differential splicing: Generates isoforms with distinct pharmacological profiles
Cysteine residues: In extracellular loops for disulfide bond formation
Palmitoylation sites: For membrane localization
Unlike most 5-HT receptors, HTR6 exclusively couples to Gs proteins, making it unique in the 5-HT receptor family.
Normal Function
HTR6 mediates important brain functions:
Cognitive enhancement: Hippocampal and cortical signaling improves learning and memory
Mood regulation: Modulates serotonergic signaling in limbic regions
Food intake: Hypothalamic HTR6 regulates appetite
Neuroprotection: May have trophic effects on [neurons](/entities/neurons)
neurodegeneration" style="color:#4fc3f7;margin:1.5rem 0 0.6rem;font-size:1.15rem;font-weight:700;border-bottom:2px solid rgba(79,195,247,0.3);padding-bottom:0.3rem">Role in Neurodegeneration
Alzheimer's Disease
HTR6 is highly expressed in brain regions affected by AD ([hippocampus](/brain-regions/hippocampus), cortex). HTR6 antagonists (e.g., idalopirdine) have been investigated as cognitive enhancers, though clinical trials showed mixed results. The receptor may modulate cholinergic signaling relevant to AD.
Parkinson's Disease
HTR6 in the basal ganglia influences motor control and may be affected in PD. Novel HTR6 modulators are being explored for PD cognitive symptoms.
HTR6 antagonists show antidepressant-like effects in animal models. Combined serotonin reuptake inhibition with HTR6 antagonism may offer enhanced therapeutic benefit.
HTR6 is a potential target for treating cognitive deficits in schizophrenia. Atypical antipsychotics with HTR6 antagonist activity may provide cognitive benefits.
Therapeutic Targeting
| Drug Class | Examples | Mechanism | Status | |-----------|----------|-----------|--------| | Antagonists | Idalopirdine, SB-742457 | Block receptor signaling | Research/Clinical trials | | Inverse Agonists | Antagonists with negative efficacy | Inhibit constitutive activity | Research | | Antidepressant Augmentation | Combined SSRIs + HTR6 antagonists | Enhanced efficacy | Research |
The study of Htr6 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.